Related references
Note: Only part of the references are listed.Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4
Song Chen et al.
AGE (2012)
The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease
Lana Kupershmidt et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Antioxidants for Alzheimer Disease A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures
Douglas R. Galasko et al.
ARCHIVES OF NEUROLOGY (2012)
Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus
Akiko Sheala Shingo et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
The role of iron as a mediator of oxidative stress in Alzheimer disease
Rudy J. Castellani et al.
BIOFACTORS (2012)
(Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains
Lin Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain
Dinesh K. Dhull et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2012)
Neuroprotective Effect of Cyclooxygenase Inhibitors in ICV-STZ Induced Sporadic Alzheimer's Disease in Rats
Dinesh Kumar Dhull et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Developing ß-secretase inhibitors for treatment of Alzheimer's disease
Arun K. Ghosh et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
Lana Kupershmidt et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2012)
RUTIN PREVENTS COGNITIVE IMPAIRMENTS BY AMELIORATING OXIDATIVE STRESS AND NEUROINFLAMMATION IN RAT MODEL OF SPORADIC DEMENTIA OF ALZHEIMER TYPE
H. Javed et al.
NEUROSCIENCE (2012)
CHANGES IN HIPPOCAMPAL SYNAPSES AND LEARNING-MEMORY ABILITIES IN A STREPTOZOTOCIN-TREATED RAT MODEL AND INTERVENTION BY USING FASUDIL HYDROCHLORIDE
Y. Hou et al.
NEUROSCIENCE (2012)
Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats
Vivek Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
Sonia C. Correia et al.
AGEING RESEARCH REVIEWS (2011)
Treating transgenic Alzheimer mice with a beta-secretase inhibitor, what have we learned?
Jordan Tang et al.
AGING-US (2011)
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
Cholesterol Level and Statin Use in Alzheimer Disease I. Review of Epidemiological and Preclinical Studies
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Cholesterol Level and Statin Use in Alzheimer Disease II. Review of Human Trials and Recommendations
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment
Santoshkumar Tota et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor
Gunjan Saxena et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model
Teresa Ponce-Lopez et al.
BRAIN RESEARCH (2011)
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
Orestes V. Forlenza et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Neuroprotector effect of p,p′-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: contribution of antioxidant mechanism
Simone Pinton et al.
CELL BIOCHEMISTRY AND FUNCTION (2011)
Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimer's Disease: Two Phase 3 Studies
C. Harrington et al.
CURRENT ALZHEIMER RESEARCH (2011)
Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats
Shubham Misra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model
Rahul Agrawal et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
Yi-Fei Dong et al.
FASEB JOURNAL (2011)
Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis
Domenico Bosco et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats
Ana Carolina Tramontina et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study
Melita Salkovic-Petrisic et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling
Natasa Dragicevic et al.
JOURNAL OF PINEAL RESEARCH (2011)
Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function
Shuko Takeda et al.
MOLECULAR BIOSYSTEMS (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
NOVEL MOLECULAR TARGETS OF THE NEUROPROTECTIVE/NEURORESCUE MULTIMODAL IRON CHELATING DRUG M30 IN THE MOUSE BRAIN
L. Kupershmidt et al.
NEUROSCIENCE (2011)
2.14.3 NEURORESTORATIVE, NEUROPROTECTIVE AND CELL CYCLE ARREST ACTIVITY OF NOVEL MULTI TARGET DRUGS IN ANIMAL MODELS OF PARKINSON'S DISEASE
M.B.H. Youdim
PARKINSONISM & RELATED DISORDERS (2011)
Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice
Santoshkumar Tota et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
Miguel Medina et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Potential of ezetimibe in memory deficits associated with dementia of alzheimer′s type in mice
Nirmal Singh et al.
INDIAN JOURNAL OF PHARMACOLOGY (2010)
Carvedilol Reestablishes Long-Term Potentiation in a Mouse Model of alzheimer's Disease
Isabel Arrieta-Cruz et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [F-18]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease
Sofia Tzimopoulou et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin
Leticia Rodrigues et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Effects of Erythropoietin on Memory Deficits and Brain Oxidative Stress in the Mouse Models of Dementia
Rohit Kumar et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2010)
Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
E. M. Toledo et al.
MOLECULAR PSYCHIATRY (2010)
Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow
Himani Awasthi et al.
LIFE SCIENCES (2010)
Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia
Puneet Rinwa et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Oxidative stress in Alzheimer disease: A possibility for prevention
David J. Bonda et al.
NEUROPHARMACOLOGY (2010)
Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
Luis Escribano et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Organoselenium improves memory decline in mice: Involvement of acetylcholinesterase activity
Simone Pinton et al.
NEUROSCIENCE LETTERS (2010)
Memory restorative role of statins in experimental dementia: an evidence of their cholesterol dependent and independent actions
Yogita Dalla et al.
PHARMACOLOGICAL REPORTS (2010)
Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat
Rahul Agrawal et al.
PHARMACOLOGICAL RESEARCH (2010)
Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats
Gunjan Saxena et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
Lusine Danielyan et al.
REJUVENATION RESEARCH (2010)
'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
Kathleen R. Zahs et al.
TRENDS IN NEUROSCIENCES (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model
Ahmet Turan Isik et al.
AGE (2009)
Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin
Santoshkumar Tota et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats
Tauheed Ishrat et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
Tauheed Ishrat et al.
BRAIN RESEARCH (2009)
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor
Rahul Deshmukh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT)
Tauheed Ishrat et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia
Baljinder Kaur et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-beta
Melita Salkovic-Petrisic et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Hippocampal Alterations in Rats Submitted to Streptozotocin-Induced Dementia Model are Prevented by Aminoguanidine
Leticia Rodrigues et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study
Harald Hampel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Statins Reduce the Neurofibrillary Tangle Burden in a Mouse Model of Tauopathy
Moran Boimel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Qiu-Lan Ma et al.
JOURNAL OF NEUROSCIENCE (2009)
Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats
Atish Kumar Prakash et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2009)
Consumption of Grape Seed Extract Prevents Amyloid-beta Deposition and Attenuates Inflammation in Brain of an Alzheimer's Disease Mouse
Yan-Jiang Wang et al.
NEUROTOXICITY RESEARCH (2009)
Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats
Vinod Tiwari et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: An observational study
Ihab M. Hajjar et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2008)
Wheel-running in a transgenic mouse model of Alzheimer's disease:: Protection or symptom?
Helene Richter et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
New polyphenols active on β-amyloid aggregation
Celine Riviere et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Therapeutic potential of resveratrol in Alzheimer's disease
Valerie Vingtdeux et al.
BMC NEUROSCIENCE (2008)
Study of neuroprotection of donepezil, a therapy for Alzheimer's disease
S. Akasofu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice
Gunjan Saxena et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
Nektaria Nicolakakis et al.
JOURNAL OF NEUROSCIENCE (2008)
Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil
Bhupesh Sharma et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Effects of treadmill exercise on memory and c-Fos expression in the hippocampus of the rats with intracerebroventricular injection of streptozotocin
Yong-Seok Jee et al.
NEUROSCIENCE LETTERS (2008)
Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia
Bhupesh Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice
Jenna C. Carroll et al.
JOURNAL OF NEUROSCIENCE (2007)
Iron: The redox-active center of oxidative stress in Alzheimer disease
Rudy J. Castellani et al.
NEUROCHEMICAL RESEARCH (2007)
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
Patrick L. McGeer et al.
NEUROBIOLOGY OF AGING (2007)
Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein
Edna Gruenblatt et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice
Gunjan Saxena et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats
Shai Shoham et al.
NEUROPHARMACOLOGY (2007)
Causes of oxidative stress in Alzheimer disease
X. Zhu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease
M. Degerman Gunnarsson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Alzheimer disease - No target for statin treatment. A mini review
Siegfried Hoyer et al.
NEUROCHEMICAL RESEARCH (2007)
Reduction of soluble Aβ and Tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles
Salvatore Oddo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats
Asif R. Pathan et al.
LIFE SCIENCES (2006)
Genetic correlates of behavioral endophenotypes in Alzheimer disease:: Role of COMT, 5-HTTLPR and APOE polymorphisms
B. Borroni et al.
NEUROBIOLOGY OF AGING (2006)
Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer's disease
Jun Wang et al.
FASEB JOURNAL (2006)
Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats
Tauheed Ishrat et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Ward A. Pedersen et al.
EXPERIMENTAL NEUROLOGY (2006)
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway
M Salkovic-Petrisic et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern
T. Melnikova et al.
NEUROSCIENCE (2006)
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model
D Van Dam et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats
S Sonkusare et al.
LIFE SCIENCES (2005)
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
M Hashimoto et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases
MBH Youdim et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease - A placebo-controlled study
ER Peskind et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2005)
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
S Hoyer
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease
E Grünblatt et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease
R Minkeviciene et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Idebenone treatment fails to slow cognitive decline in Alzheimer's disease
LJ Thal et al.
NEUROLOGY (2003)
Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats
M Sharma et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial
SA Shumaker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
SA Montgomery et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment
RW Stackman et al.
EXPERIMENTAL NEUROLOGY (2003)
Chronic treatment with trans rosveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats
M Sharma et al.
LIFE SCIENCES (2002)
N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease
H Bi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment
M Sharma et al.
LIFE SCIENCES (2001)
Effect of Ginkgo biloba extract (EGb 761) on glucose metabolism-related markers in streptozotocin-damaged rat brain
T Loffler et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Regulation of APP cleavage by α-, β- and γ-secretases
J Nunan et al.
FEBS LETTERS (2000)
Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
L Hong et al.
SCIENCE (2000)
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease - A randomized controlled trial
RI Mulnard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
